Besides aberrant expression in TNBC, UBR5 was amplified in ~22% of OC in a TCGA (The Cancer Genome Atlas)-based analysis, and its expression in patient specimens was increased in 47% of OC tumor tissues examined14,16. Here, UBR5 is linked to cancer.